首页> 外文OA文献 >Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Transcription Polymerase Chain Reaction of the PML/RARα Fusion Gene

【2h】

Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Transcription Polymerase Chain Reaction of the PML/RARα Fusion Gene

机译：第二次缓解中急性早幼粒细胞白血病的自体骨髓移植：PML /RARα融合基因的逆转录聚合酶链反应预先进行预留残留疾病评估的预后相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Giovanna Meloni; Daniela Diverio; Marco Vignetti; Giuseppe Avvisati; Saveria Capria; Maria Concetta Petti; Franco Mandelli; Francesco Lo Coco;
展开▼
作者单位

展开▼
年度 1997
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse (vol 82, pg 1264, 1993) [J] . Huang W., Sun G-L, Li X-S, Blood: The Journal of the American Society of Hematology . 2015,第15期

机译：急性早幼粒细胞白血病：两种主要PML-RARα亚型的临床意义以及通过逆转录酶/聚合酶链反应预测复发的最小残留病的检测（第82卷，第1264页，1993年）
2. Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by ch… | Haematologica [J] . D Nemet, B Grahovac, B Labar, Haematologica . 1995,第3期

机译：通过聚合酶链反应法对全反式维甲酸继之以胆碱酯酶治疗的患者的PML / RARα（视黄酸受体-α）融合转录本进行分子监测，以监测急性早幼粒细胞白血病中的最小残留疾病。血液学
3. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow. [J] . Inokuchi K, Iwakiri R, Futaki M, Leukemia and lymphoma . 1998,第5a6期

机译：具有PML / RAR alpha或AML1 / ETO mRNA的急性骨髓性白血病的最小残留病，以及骨髓中可能的T和自然杀伤细胞的表型分析。
4. Arsenic Salvage Is Superior to Chemotherapy and Bone Marrow Transplantation for Relapsed Acute promyelocytic Leukemia: Ten Years of Experience from Hong Kong [C] . W.Y. Au, R. Liang, A.K.W. Lie, European Haematology Association . 2002

机译：砷救生优于化疗和骨髓移植复发急性突出细胞细胞白血病：来自香港的十年经验
5. PCR amplification of IgH rearrangements for the assessment of minimal residual disease in PBSC harvests for autologous transplantation following administration of monocyte-derived growth factor. [D] . Keenan, James R. 2003

机译：IgH重排的PCR扩增用于评估单核细胞衍生生长因子后自体移植PBSC收获物中的最小残留病害。
6. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. [O] . W H Miller Jr, A Kakizuka, S R Frankel, 1992

机译：重排的视黄酸受体α的逆转录聚合酶链反应可明确诊断并检测出急性早幼粒细胞白血病的最小残留病。
7. Prolonged molecular remission after PML/RARα-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft? [O] . MA Sanz, J de la Rubia, S Bonanad, 1998

机译：PML /RARα-阳性自体外周血血液干细胞移植术后长期分子缓解急性突出细胞粒细胞白血病：在移植物中是相关预防植物的最小残余疾病吗？

Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Transcription Polymerase Chain Reaction of the PML/RARα Fusion Gene

著录项

相似文献

相关主题

期刊订阅